Revamped Drug Reimbursement Reviews Expected In Canada Soon

 
• By Neena Brizmohun
  
Extreme close-up image of tablets and container with roll of money
The CDA-AMC evaluates the cost-effectiveness of medicines (Shutterstock)

More from Health Technology Assessment

More from Canada